Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 4Stomach Neoplasms 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Breast Neoplasms 3Spinocerebellar Degenerations 2Recurrence 2Rectal Neoplasms 2Neoplasms 2Gastric / Gastroesophageal Junction Adenocarcinoma 2EBV-associated Tumors 2Carcinoma, Non-Small-Cell Lung 2Vascular Complications 1Triple Negative Breast Neoplasms 1Solid Tumors 1Solid Cancers 1Small Cell Lung Carcinoma 1Pathologic Complete Response 1Pancreatic Neoplasms 1Pancreatic Cancer Metastatic 1Oropharyngeal Neoplasms 1Nasopharyngeal Cancinoma (NPC) 1Mouth Neoplasms 1Melanoma 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Head and Neck Neoplasms 1Gynecologic Cancers 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1

Interventions

sintilimab 1Tyrosine Kinase Inhibitors 1SHR-1701 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Immune Checkpoint Inhibitors 1HMPL-013 1Decitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Colorectal Cancer Metastatic × Immune Checkpoint Inhibitors × Clear all
NCT07486492 2026-03-20

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

The First Affiliated Hospital of Xiamen University

Phase EARLY_PHASE1 Not yet recruiting
10 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡